Multinational Pharma Companies Franchise
Pharma Business Opportunity - BarwalaGet multinational Pharma Franchise Opportunities in India. Monark Biocare is the preferred nation for pharmaceutical generation, with low charges for research and development as well as production of drugs.
About Company
Year of Establishment
2011
Nature of Business
Pharma Franchise Company & Pharma Manufacturing Company
Number of Employees
11 to 25 People
Annual Turnover
Rs. 10 - 25 Crore
Member Since Rednirus Mart
Jun 2021
GST
06AAHCM5807H1ZG
Import Export Code (IEC)
AAHCM*****
Monark Biocare with just few products and continuously progressing under the table guidance of our Managing Experts. We are engaged in manufacturing and supplying a wide range of formulations such as tablets, capsules, injections and new products that are DCGI Approved. Our huge product folio made us the first choice of many customers. We have a huge supply chain which is spread all over the country to reach out our products to every needy patient.
We have always focused on improving the health of community by offering safe efficacious and quality products. We have progressed firmly to deliver the products to our customer from such units which are designed as per WHO-GMP and other international regulatory standards. Presently we have DCIG approved products. At the same time, we strive hard to ensure prompt delivery, leakage & breakage prove the packaging of all our formulated medicines range. By focusing on innovation, quality, and simplicity in our manufacturing approach, and by taking responsibility of cost efficiency, we are creating a strong and vibrant brand that offers quality pharmaceuticals at prices economical prices.
We do not compromise in terms of excellence, therefore follow various quality testing measures in our operations. This further helps us to deliver quality tested and effective range in the market. Besides, to make easy and hassle free transaction of money, we provide convenient payment options to the clients, which includes DD, Cheque and Cash.